Zobrazeno 1 - 10
of 52
pro vyhledávání: '"García-López FJ"'
Autor:
Labrador Cañadas MV, Pàmpols Ros T, Dulín Íñiguez E, Pérez Aytés A, García Sagredo JM, Díaz de Bustamante A, Martín Arribas C, García López FJ, Nicolás Jiménez P
Publikováno v:
REVISTA ESPANOLA DE SALUD PUBLICA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Decision making for the development of newborn screening programs is based on not only medical but also social concerns and involves different stakeholders. Part III of the article focuses on their role in the governance of the programs. First of all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::5bccac76ef32f599514bd1861d697c32
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13817
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13817
Autor:
Aurrecoechea B, Gómez-Ullate P, García-López Fj, Amenábar Jj, I Lampreabe, G. García-Erauzkin
Publikováno v:
Transplantation. 65:653-661
Background. In renal transplantation, triple-drug therapy (low-dose cyclosporine [CsA] combined with azathioprine plus steroids) has been replacing double-drug therapy (CsA plus steroids) in clinical practice without much evidence in favor of either
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::610e9a17fbbddd124c0d58250682deae
https://doi.org/10.1097/00007890-199803150-00009
https://doi.org/10.1097/00007890-199803150-00009
Autor:
Honrubia T, García López FJ, Franco N, Mas M, Guevara M, Daguerre M, Alía I, Algora A, Galdos P
Publikováno v:
CHEST; Dec2005, Vol. 128 Issue 6, p3916-3924, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alcalde Cabero, Enrique, Almazan Isla, Javier, García López, Fernando J., Ara Callizo, José Ramón, Avellanal, Fuencisla, Casasnovas Pons, Carlos, Cemillán, Carlos, Cuadrado, José Ignacio, Duarte, Jacinto, Fernández Pérez, María Dolores, Fernández, Óscar, García Merino, Juan Antonio, García Montero, Rosa, Montero, Dolores, Pardo, Julio, Rodríguez Rivera, Francisco Javier, Ruiz Tovar, María, Pedro Cuesta, Jesús de, Spanish GBS Epidemiology Study Group
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
Dipòsit Digital de la UB
Universidad de Barcelona
BMC Neurology
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
Dipòsit Digital de la UB
Universidad de Barcelona
BMC Neurology
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
BACKGROUND: Studies have shown a slight excess risk in Guillain-Barré syndrome (GBS) incidence associated with A(H1N1)pdm09 vaccination campaign and seasonal trivalent influenza vaccine immunisations in 2009-2010. We aimed to assess the incidence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98d437f04ccf78c099125061c55d91ad
http://hdl.handle.net/2445/126747
http://hdl.handle.net/2445/126747
Autor:
Islam N; School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., García López FJ; National Epidemiology Centre, Health Institute Carlos III, Madrid, Spain; Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Spain. Electronic address: fjgarcial@isciii.es., Jdanov DA; Max Planck Institute for Demographic Research, Rostock, Germany; International Laboratory for Population and Health, National Research University Higher School of Economics, Moscow, Russian Federation., Royo-Bordonada MÁ; National School of Public Health, Health Institute Carlos III, Madrid, Spain., Khunti K; Diabetes Research Center, University of Leicester, NIHR Applied Research Collaboration-East Midlands, Leicester General Hospital, Leicester, United Kingdom., Lewington S; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; Health Data Research UK Oxford, University of Oxford, Oxford, United Kingdom., Lacey B; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., White M; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom., Morris EJA; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; Big Data Institute, University of Oxford, Oxford, United Kingdom., Zunzunegui MV; École de Santé Publique, Université de Montréal, Montréal, Québec, Canada.
Publikováno v:
Gaceta sanitaria [Gac Sanit] 2024 Nov 04; Vol. 38, pp. 102424. Date of Electronic Publication: 2024 Nov 04.
Autor:
Pastor-Barriuso R; Carlos III Health Institute (ISCIII), Madrid, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain., Padrón-Monedero A; Carlos III Health Institute (ISCIII), Madrid, Spain., Almazán-Isla J; Carlos III Health Institute (ISCIII), Madrid, Spain.; Consortium for Biomedical Research in Neurodegenerative Diseases, Madrid, Spain., García López FJ; Carlos III Health Institute (ISCIII), Madrid, Spain.; Consortium for Biomedical Research in Neurodegenerative Diseases, Madrid, Spain., de Pedro-Cuesta J; Carlos III Health Institute (ISCIII), Madrid, Spain.; Consortium for Biomedical Research in Neurodegenerative Diseases, Madrid, Spain., Damián J; Carlos III Health Institute (ISCIII), Madrid, Spain.; Consortium for Biomedical Research in Neurodegenerative Diseases, Madrid, Spain.
Publikováno v:
International journal of public health [Int J Public Health] 2024 Oct 07; Vol. 69, pp. 1607344. Date of Electronic Publication: 2024 Oct 07 (Print Publication: 2024).